CASTLE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized
CASTLE BIOSCIENCES, INC. (CSTL) reported Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized of 856.54 thousand shares for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized · last filed 2020-11-09
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for the quarter ending 2020-09-30 was 0.00 shares.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for the quarter ending 2020-06-30 was 0.00 shares.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for the quarter ending 2020-03-31 was 856.54K shares.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for the quarter ending 2019-12-31 was 0.00 shares.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2019 was 2.08M shares, a 406.10% increase from fiscal 2018.
- CASTLE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2018 was 410.17K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 12 month |
|---|---|---|---|---|
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 0.00 shares derived: sum of 2 quarters · filed 2020-11-09 | 856.54K shares 10-Q · filed 2020-11-09 | 856.54K shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 856.54K shares 10-Q · filed 2020-08-10 | 856.54K shares derived: sum of 3 quarters · filed 2020-08-10 | |
| 2020-03-31 | 856.54K shares 10-Q · filed 2020-05-11 | 856.54K shares derived: sum of 2 quarters · filed 2020-05-11 | ||
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | 2.08M shares 10-K · filed 2020-03-10 | ||
| 2019-09-30 | 2.08M shares 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | 410.17K shares 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |